Cabaletta Bio

1 serious warning sign in Cabaletta Bio’s filings.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 23 Mar 2026, plus the 10-Q filed 13 Aug 2026 and 9 later 8-Ks.

• Doubt it can keep going

  Serious

  The company or its auditor warned it may not have enough money to last the next year.

  “Accordingly, the Company has concluded that substantial doubt exists about the Company’s ability to continue as a going concern.”

  Show the full paragraph

  The Company expects that its current cash and cash equivalents may be sufficient to fund operations for at least the next twelve months from the date of issuance of these unaudited condensed consolidated financial statements; however, the Company's cash forecast contains estimates and assumptions with significant variability and management cannot predict the amount or timing of all expenditures with certainty. The Company’s ultimate success depends on the outcome of its research and development activities. Management expects to incur additional losses in the future as it continues its research and development and will need to raise additional capital to fully implement its business plan and to fund its operations. The Company intends to raise such additional capital through a combination of equity offerings, debt financings, government funding arrangements, strategic alliances or other sources. However, if such financing is not available at adequate levels and on a timely basis, or such agreements are not available on favorable terms, or at all, as and when needed, the Company will need to reevaluate its operating plan and may be required to delay or discontinue the development of one or more of its product candidates or operational initiatives. Accordingly, the Company has concluded that substantial doubt exists about the Company’s ability to continue as a going concern. The a ccompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business.

  From the 10-Q filed 13 August 2026, Part I, Item 1. Financial Statements. Read it in the filing

Cheap for a reason is the question the numbers cannot answer.

Whether the price already reflects the risks is what the deep dive is for.